Characterisation of antibody conjugated particles and their influence on diagnostic assay response

Abstract

The batch-to-batch assay performance ‘activity’ of antibody conjugated particles is often variable, leading to poor reproducibility between different production batches. DCS analysis provides a quantitative method to characterise particle oligomerisation, providing a rationale for variable assay performance of different conjugate batches.